These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27611957)

  • 1. Buying drugs on a Darknet market: A better deal? Studying the online illicit drug market through the analysis of digital, physical and chemical data.
    Rhumorbarbe D; Staehli L; Broséus J; Rossy Q; Esseiva P
    Forensic Sci Int; 2016 Oct; 267():173-182. PubMed ID: 27611957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing cryptomarkets for drugs. A characterisation of sellers and buyers over time.
    Tzanetakis M
    Int J Drug Policy; 2018 Jun; 56():176-186. PubMed ID: 29449105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A geographical analysis of trafficking on a popular darknet market.
    Broséus J; Rhumorbarbe D; Morelato M; Staehli L; Rossy Q
    Forensic Sci Int; 2017 Aug; 277():88-102. PubMed ID: 28624673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forensic drug intelligence and the rise of cryptomarkets. Part I: Studying the Australian virtual market.
    Broséus J; Morelato M; Tahtouh M; Roux C
    Forensic Sci Int; 2017 Oct; 279():288-301. PubMed ID: 28927690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterising the online weapons trafficking on cryptomarkets.
    Rhumorbarbe D; Werner D; Gilliéron Q; Staehli L; Broséus J; Rossy Q
    Forensic Sci Int; 2018 Feb; 283():16-20. PubMed ID: 29245040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studying illicit drug trafficking on Darknet markets: Structure and organisation from a Canadian perspective.
    Broséus J; Rhumorbarbe D; Mireault C; Ouellette V; Crispino F; Décary-Hétu D
    Forensic Sci Int; 2016 Jul; 264():7-14. PubMed ID: 26978791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forensic drug intelligence and the rise of cryptomarkets. Part II: Combination of data from the physical and virtual markets.
    Morelato M; Broséus J; De Grazia A; Tahtouh M; Esseiva P; Roux C
    Forensic Sci Int; 2018 Jul; 288():201-210. PubMed ID: 29763810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hidden wholesale: The drug diffusing capacity of online drug cryptomarkets.
    Aldridge J; Décary-Hétu D
    Int J Drug Policy; 2016 Sep; 35():7-15. PubMed ID: 27260863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery dilemmas: How drug cryptomarket users identify and seek to reduce their risk of detection by law enforcement.
    Aldridge J; Askew R
    Int J Drug Policy; 2017 Mar; 41():101-109. PubMed ID: 28089207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Illicit drug prices and quantity discounts: A comparison between a cryptomarket, social media, and police data.
    Moeller K; Munksgaard R; Demant J
    Int J Drug Policy; 2021 May; 91():102969. PubMed ID: 33041184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Who sells what? Country specific differences in substance availability on the Agora cryptomarket.
    Van Buskirk J; Naicker S; Roxburgh A; Bruno R; Burns L
    Int J Drug Policy; 2016 Sep; 35():16-23. PubMed ID: 27520115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonmedical prescription psychiatric drug use and the darknet: A cryptomarket analysis.
    Cunliffe J; Décary-Hêtu D; Pollak TA
    Int J Drug Policy; 2019 Nov; 73():263-272. PubMed ID: 30772109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical profiling: A tool to decipher the structure and organisation of illicit drug markets: An 8-year study in Western Switzerland.
    Broséus J; Baechler S; Gentile N; Esseiva P
    Forensic Sci Int; 2016 Sep; 266():18-28. PubMed ID: 27173376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Preliminary Inventory of Kratom
    Prevete E; Catalani V; Singh D; Kuypers KPC; Theunissen EL; Townshend HD; Banayoti H; Ramaekers JG; Pasquini M; Corazza O
    J Psychoactive Drugs; 2024; 56(4):485-495. PubMed ID: 37702482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transparency paradox. Building trust, resolving disputes and optimising logistics on conventional and online drugs markets.
    Tzanetakis M; Kamphausen G; Werse B; von Laufenberg R
    Int J Drug Policy; 2016 Sep; 35():58-68. PubMed ID: 26809972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of restricting the legal supply of prescription opioids on buying through online illicit marketplaces: interrupted time series analysis.
    Martin J; Cunliffe J; Décary-Hétu D; Aldridge J
    BMJ; 2018 Jun; 361():k2270. PubMed ID: 29899119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An island apart? Risks and prices in the Australian cryptomarket drug trade.
    Cunliffe J; Martin J; Décary-Hétu D; Aldridge J
    Int J Drug Policy; 2017 Dec; 50():64-73. PubMed ID: 29055855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring Televend, an innovative combination of cryptomarket and messaging app technologies for trading prohibited drugs.
    Barratt MJ; Lamy FR; Engel L; Davies E; Puljevic C; Ferris JA; Winstock AR
    Drug Alcohol Depend; 2022 Feb; 231():109243. PubMed ID: 34999269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seller's reputation and capacity on the illicit drug markets: 11-month study on the Finnish version of the Silk Road.
    Nurmi J; Kaskela T; Perälä J; Oksanen A
    Drug Alcohol Depend; 2017 Sep; 178():201-207. PubMed ID: 28654873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social influence in the darknet market: The impact of product descriptions on cocaine sales.
    Andrei F; Veltri GA
    Int J Drug Policy; 2024 Feb; 124():104328. PubMed ID: 38245917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.